Book a FREE no obligation demo with one of our specialists to see how Plimsoll can help you
Book a free Demo
Bausch & lomb u.k. Ltd
Registration Number
00143720Incorporation Date
28/04/1916Last Annual Return
Not availableAddress
One Fleet Place, London, London. EC4M 7WS
Website
www.bausch.co.ukAudit Fees
£165,000Secretary
Not available
Directors
Active
Mr Eberhard Karl Heinz Kuehne (60 yrs)
Active
Ms Jennifer Elizabeth White (60 yrs)
Active
Manoj Panda (49 yrs)
Proposed Year |
|||||
---|---|---|---|---|---|
Period Ending | 31-Dec-20 | 31-Dec-21 | 31-Dec-22 | 31-Dec-23 | 29-Dec-24 |
Weeks | 52 | 52 | 52 | 52 | 52 |
Total Sales (£000) | 65144 | 81480 | 90838 | 97465 | 98887 |
Directors Fees | 675 | 275 | 259 | 196 | 196 |
Gross Profits | 12532 | 13846 | 16997 | 12745 | 12931 |
Value Added | 14760 | 17382 | 17286 | 17424 | 18647 |
Trading Profit | 3172 | 5270 | 3916 | 3552 | 5852 |
Depreciation | 956 | 1246 | 1024 | 1078 | |
Non-Trading Income | 0 | -488 | 2250 | 2250 | 0 |
Total Interest Charges | 828 | 795 | 462 | 296 | 266 |
Pre-tax Profit | 1388 | 2741 | 4680 | 4428 | 4616 |
Retained Profit (Shareholders Funds) | -622 | 2252 | 3955 | 4353 | 2657 |
Fixed Assets | 3511 | 3589 | 3593 | 3255 | 3092 |
Intangibles | 265 | 0 | 0 | 0 | 0 |
Intermediate Assets | 30362 | 25635 | 24222 | 24378 | 23159 |
Stocks | 5377 | 3990 | 4042 | 4337 | 3667 |
Debtors | 12363 | 14490 | 15408 | 16520 | 14247 |
Cash or Equivalent | 5542 | 10577 | 1726 | 2390 | 1990 |
Total Current Assets | 23282 | 29057 | 21176 | 23247 | 19904 |
Creditors | 558 | 914 | 1270 | 701 | 818 |
Short Term Borrowing | 24421 | 23454 | 9421 | 7499 | 0 |
Other Current Liabilities | 11577 | 10797 | 11091 | 11097 | 11097 |
Total Current Liabilities | 36556 | 35165 | 21782 | 19297 | 11915 |
Net Current Assets | -13274 | -6108 | -606 | 3950 | 7989 |
Shareholders Funds | 20864 | 23116 | 27071 | 31424 | 34081 |
Total Loan Capital | 0 | 0 | 0 | 0 | 0 |
Other Capital Employed | 0 | 0 | 138 | 159 | 159 |
Total Capital Employed | 20864 | 23116 | 27209 | 31583 | 34240 |
Pretax Profit Margin % | 2.13 | 3.36 | 5.15 | 4.54 | 4.67 |
Sales Growth % | -26 | 25 | 11 | 7 | 1 |
Pretax Profit Growth % | 49 | 97 | 71 | -5 | 4.00 |
Debtor Ratio Days | 69 | 65 | 62 | 62 | 52.4422921048582 |
Creditor Ratio Days | 3 | 4 | 5 | 3 | 3.0107074334376 |
Stock Turnover | 12 | 20 | 22 | 22 | 26.9674890477288 |
Sales £000 / Employee | 410 | 512 | 522 | 560 | 616.158045977012 |
Value Added £000/Empl. | 93 | 109 | 99 | 100 | 116.188055489851 |
Av. Remun. £000 / Empl. | 73 | 76 | 77 | 80 | 79.7241379310345 |
Total Empl. Remu. £000 | 11588 | 12112 | 13370 | 13872 | 12794.9124695512 |
Employees | 159 | 159 | 174 | 174 | 160.489819038488 |
Pretax Profit/Total Assets % | 2 | 5 | 10 | 9 | 10 |
Company Summary
- The Plimsoll Chart is high and rising indicating an improvement in financial strength, but below the industry average.
- Total Sales have increased by 7.3% in the latest year, well above the industry average of -0.4%.
- Sales per Employee is £560,000 which is well above the industry average of £249,000.
- The average salary is £80,000 which is well above the industry average of £52,000.
- The company is ranked among the fastest growing in terms of sales growth in the latest year.
- Non Trading Income of £2.3m makes a large contribution to pretax profits of £4.4m.
- Formal debt of the company has decreased by £1.9m, a fall of 20%.
- The company is among the Top 5 companies listed as a Best Trading Partner (see section 1c).
- The company is among the Top 33 Leaders in Efficiency.
- The company is among the Top 50 companies listed under the Pretax Profit Return on Total Assets category (see section 3.4c).
- The company is among the Top 91 companies listed under the Pretax Profits category (see section 3.2c).
Company Summary
The company currently has £97.5m sales and made £4.4m, by following the proposal plan, sales would be level and profits would stay thesame.
Key Attractiveness Features
- PRIVATELY OWNED
- ADD £97.5m TO SALES
- FEW DIRECTORS
Acquisition Attractiveness Rating
- Low number of shareholders
- Company is privately owned
- Low number of directors
- Sales growth above the industry average
- Low financial rating
- High gross earnings
- Big difference between current and future value
- Directors fees represent high proportion of profits
- Average age of directors is high

Company Valuation
Proposed Year |
|||||
---|---|---|---|---|---|
Period Ending | 31-Dec-20 | 31-Dec-21 | 31-Dec-22 | 31-Dec-23 | 29-Dec-24 |
Total Sales (£000) | 65144 | 81480 | 90838 | 97465 | 98887 |
Pre-tax Profit (£000) | 1388 | 2741 | 4680 | 4428 | 4616 |
Total Value (£000) | 66333 | 69199 | 63020 | 61840 | 69555 |
Asset Value (£000) | 51878 | 47704 | 47265 | 48490 | 44165 |
Goodwill (£000) | 14455 | 21495 | 15755 | 13350 | 25390 |
Liabilities (£000) | -31014 | -24588 | -20194 | -17066 | -10084 |
Equity Value (£000) | 35319 | 44611 | 42826 | 44774 | 59471 |
Total Value Formula: (Pretax Profit + Interest Payments - Non Trading Income + Directors Fees) * 5 plus (Fixed Assets + Intangibles + Intermediate Assets + Stocks + Debtors)
Shareholders / Ownership
BAUSCH+LOMB NETHERLANDS B.V.
Immediate Shareholder: See Shareholders
Subsidiaries
STERIMEDIX LTD
Acquisition / Valuation Comments
This company has been established 109 years.
The number of shareholders is low (1)
The value of the company has fallen in each of the last 2 years.
The value of the company has fluctuated in the last 2 years.
The total value of the company is currently £61.8m including debts.
The equity value is high, indicating low levels of total liabilities.
This company is rated HIGHLY ATTRACTIVE in terms of attractiveness.
The proposed year is based on achieving a 10% return on total assets.
The company's value would increase by 12% if the proposed business plan was followed.
The proposed plan would improve the overall financial strength of the company by 78%.
Book a FREE no obligation demo with one of our specialists to see how Plimsoll can help you
Book a free Demo